Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein

European Journal of Endocrinology

Volumn 137, Issue 6, 1997, Pages 626-630

  Kanety, Hannah ^c   Silbergeld, Aviva ^a   Klinger, Beatrice ^a   Karasik, Avraham ^c   Baxter, Robert C ^b   Laron, Zvi ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FK 780; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CHILD; DRUG EFFECT; FEMALE; HUMAN; IMMUNOBLOTTING; LARON SYNDROME; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION;

CARRIER PROTEINS; CHILD; DWARFISM; FEMALE; GLYCOPROTEINS; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PEDIGREE; TIME FACTORS;

EID: 0031438098     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370626     Document Type: Article

References (29)

1. Laron Z, Pertzelan A & Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone - a new inborn error of metabolism? Israel Journal of Medical Sciences 1966 2 152-155.
2. Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A & Daughaday WH. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone. Measurements of sulfation factor, metabolic and linear growth responses. Journal of Clinical Endocrinology and Metabolism 1971 33 332-342.
3. Laron Z. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. Journal of Clinical Endocrinology and Metabolism 1995 80 1526-1531.
4. Rosenfeld RG, Rosenbloom AL & Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocrine Reviews 1994 15 369-390.
5. Laron Z, Klinger B, Eshet R, Kanety H, Karasik A & Silbergeld A. Laron syndrome (LS) due to a post-receptor defect. Response to IGF-I treatment. Israel Journal of Medical Sciences 1993 29 757-761.
6. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ & Wood WI. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987 330 573-543.
7. Baumann G, Shaw MA & Winter RJ. Absence of the growth hormone binding protein in Laron type dwarfism. Journal of Clinical Endocrinology and Metabolism 1987 65 814-816.
8. Laron Z, Klinger B, Erster B & Silbergeld A. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. Acta Endocrinologica 1989 121 603-608.
9. Agguirre A, Donnadieu M, Job JC & Chaussain JL. Le nanisme de type Laron. Etude de la proteine liante de la GH dans 3 type observations. Archives Françaises de Pédiatrie 1991 48 5-9.
10. Buchanan CR, Maheshwari HG, Normal MR, Morrell DJ & Preece MA. Laron type dwarfism with apparently normal high affinity serum growth hormone binding protein. Clinical Endocrinology 1991 35 170-185.
11. Woods KA, Fraser NC, Postel-Vinay MC, Dusquenoy P, Savage MO & Clark AJL. A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. Journal of Clinical Endocrinology and Metabolism 1996 81 1686-1690.
12. Baxter RC. Circulating binding proteins for the insulin-like growth factor. Trends in Endocrinology and Metabolism 1993 4 91-96.
13. Baxter RC & Martin JL. Radioimmunoassay of growth-hormone dependent insulin-like growth factor binding protein in human plasma. Journal of Clinical Investigation 1986 78 1504-1512.
14. Baxter RC. Circulating levels and molecular distribution of the acid-labile subunit of the high molecular weights insulin-like growth factor binding protein complex. Journal of Clinical Endocrinology and Metabolism 1990 70 1347-1353.
15. Kanety H, Karasik A, Klinger B, Silbergeld A & Laron Z. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor binding protein-3 in the absence of growth hormone activity. Acta Endocrinologica 1993 128 144-149.
16. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S & Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: using the method for titration of binding proteins and competitive binding studies. Analytical Biochemistry 1986 154 138-143.
17. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J & Skakkebaek NE. Serum levels of insulin-like growth factor binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. Journal of Clinical Endocrinology and Metabolism 1995 80 2534-2542.
18. Chin E, Zhou J, Dai J, Baxter RC & Bondy CA. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 1994 134 2498-2504.
19. Scharf JR, Ramadori G, Braulke T & Hartmann H. Synthesis of insulinlike growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulinlike growth factor and growth hormone. Hepatology 1996 23 818-827.
20. Baxter RC, Hizuka N, Takano K, Holman SR & Asakawa K. Responses of insulin-like growth factor binding protein 1 and the IGFBP-3 complex to administration of insulin-like growth factor-1. Acta Endocrinologica 1993 128 101-108.
21. Kupfer SR, Underwood LE, Baxter RC & Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. Journal of Clinical Investigation 1993 91 391-396.
22. Laron Z, Klinger B, Blum WF, Silbergeld A & Ranke MB. IGF binding protein-3 in patients with Laron type dwarfism: effect of exogenous rIGF-1. Clinical Endocrinology 1992 36 301-304.
23. Silbergeld A, Klinger B, Keret R, Eshet R, Almonte AS & Laron Z. Serum growth hormone-binding protein (GHBP) activity is decreased by administration of insulin-like growth factor I in three Laron Syndrome siblings with normal GHBP. Proceedings of the Society for Experimental Biology and Medicine 1994 206 324-326.
24. Walker JL, Baxter RC, Young S, Pucilowska J, Clemmons DR & Underwood LE. Effects of recombinant insulin-like growth factor I (IGF-I) on IGF binding proteins (IGFBPs) and the acid labile subunit (ALS) in growth hormone insensitivity syndrome (GHIS). Growth Regulation 1993 3 109-112.
25. Uchijima Y, Takenaka A, Takahashi S & Noguchi T. Production of insulin-like growth factors and their binding proteins in primary cultures of rat liver parenchymal and nonparenchymal cells. Bioscience Biotechnology and Biochemistry 1995 59 1503-1515.
26. Noll K, Wegmann BR, Havemann K & Jaques G. Insulin-like growth factors stimulate the release of insulin-like growth factor binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines. Journal of Clinical Endocrinology and Metabolism 1996 81 2653-2662.
27. Zapf J, Hauri M, Waldvogel M, Futo E, Hasler H, Binz K, Guler HP, Schmid C & Froesch ER. Recombinant human insulin-like growth factor 1 induces its own specific carrier protein in hypophysectomized and diabetic rats. Proceedings of the National Academy of Sciences of the USA 1989 86 3813-3817.
28. Glasscosk GF, Hein AN, Miller JA, Hintz RL & Rosenfeld RG. Effects of continuous infusion of insulin like growth factor 1 and 2, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat. Endocrinology 1992 130 203-210.
29. Fiedler PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC & Clark RG. Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone, and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology 1996 137 1913-1920.